BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 32485531)

  • 1. Resveratrol - A comprehensive review of recent advances in anticancer drug design and development.
    Ahmadi R; Ebrahimzadeh MA
    Eur J Med Chem; 2020 Aug; 200():112356. PubMed ID: 32485531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of quercetin and resveratrol peptidyl derivatives as potential anticancer and antioxidant agents.
    Mrkus L; Batinić J; Bjeliš N; Jakas A
    Amino Acids; 2019 Feb; 51(2):319-329. PubMed ID: 30392096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivatives and Analogues of Resveratrol: Recent Advances in Structural Modification.
    Li QS; Li Y; Deora GS; Ruan BF
    Mini Rev Med Chem; 2019; 19(10):809-825. PubMed ID: 30686253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review on the Mechanism and Structure-activity Relationship of Resveratrol Heteroaryl Analogues.
    Xiang Y; Xu Y; Li J; Jiang J; Wang Y; Li X; Ai W; Mi P; Yang Z; Zheng Z
    Comb Chem High Throughput Screen; 2024; 27(7):947-958. PubMed ID: 37448369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newly Synthesized Imino-Derivatives Analogues of Resveratrol Exert Inhibitory Effects in Breast Tumor Cells.
    Iacopetta D; Lappano R; Mariconda A; Ceramella J; Sinicropi MS; Saturnino C; Talia M; Cirillo F; Martinelli F; Puoci F; Rosano C; Longo P; Maggiolini M
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology-based formulations for resveratrol delivery: Effects on resveratrol in vivo bioavailability and bioactivity.
    Santos AC; Pereira I; Pereira-Silva M; Ferreira L; Caldas M; Collado-González M; Magalhães M; Figueiras A; Ribeiro AJ; Veiga F
    Colloids Surf B Biointerfaces; 2019 Aug; 180():127-140. PubMed ID: 31035056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Therapeutic Targets of Resveratrol, a Plant Polyphenol, and Its Role in the Therapy of Various Types of Cancer.
    Almatroodi SA; A Alsahli M; S M Aljohani A; Alhumaydhi FA; Babiker AY; Khan AA; Rahmani AH
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Versatility of Resveratrol Derivatives.
    Nawaz W; Zhou Z; Deng S; Ma X; Ma X; Li C; Shu X
    Nutrients; 2017 Oct; 9(11):. PubMed ID: 29109374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer Potential of Resveratrol, β-Lapachone and Their Analogues.
    Ferraz da Costa DC; Pereira Rangel L; Martins-Dinis MMDDC; Ferretti GDDS; Ferreira VF; Silva JL
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32085381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol for cancer therapy: Challenges and future perspectives.
    Ren B; Kwah MX; Liu C; Ma Z; Shanmugam MK; Ding L; Xiang X; Ho PC; Wang L; Ong PS; Goh BC
    Cancer Lett; 2021 Sep; 515():63-72. PubMed ID: 34052324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of resveratrol derivatives with anti-breast cancer activity.
    Yang MF; Yao X; Chen LM; Gu JY; Yang ZH; Chen HF; Zheng X; Zheng ZT
    Arch Pharm (Weinheim); 2020 Jul; 353(7):e2000044. PubMed ID: 32342549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An updated pharmacological insight of resveratrol in the treatment of diabetic nephropathy.
    Li KX; Ji MJ; Sun HJ
    Gene; 2021 May; 780():145532. PubMed ID: 33631244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,4,4'-Trihydroxy-trans-stilbene, an analogue of resveratrol, is a potent antioxidant and cytotoxic agent.
    Cai W; Zhang L; Song Y; Zhang B; Cui X; Hu G; Fang J
    Free Radic Res; 2011 Nov; 45(11-12):1379-87. PubMed ID: 21974738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol-loaded nanomedicines for cancer applications.
    Annaji M; Poudel I; Boddu SHS; Arnold RD; Tiwari AK; Babu RJ
    Cancer Rep (Hoboken); 2021 Jun; 4(3):e1353. PubMed ID: 33655717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy.
    Fantacuzzi M; Amoroso R; Carradori S; De Filippis B
    Eur J Med Chem; 2022 Apr; 233():114242. PubMed ID: 35276424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Cancer Via Resveratrol-Loaded Nanoparticles Administration: Focusing on In Vivo Evidence.
    Santos AC; Pereira I; Magalhães M; Pereira-Silva M; Caldas M; Ferreira L; Figueiras A; Ribeiro AJ; Veiga F
    AAPS J; 2019 Apr; 21(4):57. PubMed ID: 31016543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: Identification of novel proapoptotic agents.
    Belluti F; Fontana G; Dal Bo L; Carenini N; Giommarelli C; Zunino F
    Bioorg Med Chem; 2010 May; 18(10):3543-50. PubMed ID: 20409723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3,4',5-trans-Trimethoxystilbene; a natural analogue of resveratrol with enhanced anticancer potency.
    Aldawsari FS; Velázquez-Martínez CA
    Invest New Drugs; 2015 Jun; 33(3):775-86. PubMed ID: 25720605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship of trans-resveratrol and its analogues.
    Ovesná Z; Horváthová-Kozics K
    Neoplasma; 2005; 52(6):450-5. PubMed ID: 16284688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer Activity of Stilbene-Based Derivatives.
    De Filippis B; Ammazzalorso A; Fantacuzzi M; Giampietro L; Maccallini C; Amoroso R
    ChemMedChem; 2017 Apr; 12(8):558-570. PubMed ID: 28266812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.